DRUG

Omarigliptin

1 hypothesis across 1 therapeutic domain

ALL HYPOTHESES

Repurposing candidates for Omarigliptin

Inflammatory bowel disease 1

Mediator Outcome Score Tier Lit. status Trial
DPP-4 disease activity 0.220 Mid novel signal none

Clinical trials

18 registered trials for Omarigliptin

Source: ClinicalTrials.gov

← All drugs